Volume 8, Issue 4 (12-2024)
EBHPME 2024, 8(4): 0-0 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Jalali F, Riahi L, Barkhordari Dorbash S. Analysis of Direct Costs of COVID-19 Treatment at Imam Sajjad Hospital in Shahriar. EBHPME 2024; 8 (4)
URL: http://jebhpme.ssu.ac.ir/article-1-521-en.html
URL: http://jebhpme.ssu.ac.ir/article-1-521-en.html
Department of Department of Health Services Management, School of Health Economics, Olum and Tahghigaht University, Tehran, Iran , dr.riahi@gmail.com
Abstract: (4 Views)
Background: The COVID-19 virus (Corona) is recognized as one of the greatest global health challenges in the 21st century. In addition to its unwanted effects on individual health, this disease has also had significant financial and economic impacts. Hospitals, as the most important centers for providing health services, play a very vital role.
Methods: This study investigated and analyzed direct costs of treating COVID-19 in Imam Sajjad (AS) State Hospital in Shahriar. To this end, after performing the Kolmogorov-Smirnov test and confirming the non-normality of data distribution, non-parametric Wilcoxon signed-rank test was used.
Results: The results showed that the hypothesis of normality of the data distribution for the age parameter was rejected. Also, comparisons showed that gender and age variables had an impact on treatment costs, while having an underlying disease and disease severity had no significant impact on costs. In regression analyses, costs of testing, medication, CT scan, radiology, and echocardiography had an impact on the total cost of treatment. Moreover, the cost paid by insurance was strongly correlated with the total cost of treatment.
Conclusion: The analyses showed that some factors such as gender, age, and specific costs such as testing and medications had an impact on treatment costs. These findings can help improve financial resource management in dealing with similar diseases.
Methods: This study investigated and analyzed direct costs of treating COVID-19 in Imam Sajjad (AS) State Hospital in Shahriar. To this end, after performing the Kolmogorov-Smirnov test and confirming the non-normality of data distribution, non-parametric Wilcoxon signed-rank test was used.
Results: The results showed that the hypothesis of normality of the data distribution for the age parameter was rejected. Also, comparisons showed that gender and age variables had an impact on treatment costs, while having an underlying disease and disease severity had no significant impact on costs. In regression analyses, costs of testing, medication, CT scan, radiology, and echocardiography had an impact on the total cost of treatment. Moreover, the cost paid by insurance was strongly correlated with the total cost of treatment.
Conclusion: The analyses showed that some factors such as gender, age, and specific costs such as testing and medications had an impact on treatment costs. These findings can help improve financial resource management in dealing with similar diseases.
Type of Study: Original article |
Subject:
Health Economics
Received: 2025/01/27 | Accepted: 2024/12/15 | Published: 2024/12/15
Received: 2025/01/27 | Accepted: 2024/12/15 | Published: 2024/12/15
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
